Representative Experience
Mergers and Acquisitions
- Representation of a special committee of the board of directors of Griffin Capital Essential Asset REIT II, Inc. in connection with the stock-for-stock merger with Griffin Capital Essential Asset REIT, Inc., and a related self-administration transaction. After the closing, the combined company is expected to have $4.75 Billion in assets under management
- Representation of the sale of Cole Corporate Income Trust, Inc. to Select Income REIT for approximately $3.1 billion.
- Representation of a private communications company in its merger with a publicly held communication and technology company for $323 million.
- Representation of a public chemical company in its purchase of the stock of a chemical and manufacturing company for $420 million.
- Representation of a public chemical company in its purchase of assets from an oil company for $250 million.
- Representation of a public media company in its merger with a closely held media company for $260 million.
- Representation of a public media company in its sale of assets to and separate swap of assets with a private media company for an aggregate of $238 million.
- Representation of a private conglomerate in one of its division’s purchase of assets from and the establishment of a Chinese joint venture relationship with a natural gas company for $270 million.
- Representation of a private manufacturing company in its acquisition of assets from a public paper company for $750 million.
- Representation of A-Life Medical, Inc. in the sale of its equity interests to a subsidiary of UnitedHealth Group Incorporated for $90M.
- Representation of a California private company in its acquisition and immediate sale of real estate in Quebec, Canada for approximately $100 million.
- Representation of Averion International Corp. in its acquisition of all of the outstanding capital stock of Hesperion Ltd., a Swiss corporation, for €25 million Euros.
- Representation of Safe Life Corp. in its acquisition of the outstanding capital stock of Triosyn Corp. and subsequent initial capitalization for approximately $27.5 million.
- Representation of Solstice NeuroSciences, LLC in its acquisition of all of the assets of Elan Pharmaceuticals, Inc. for approximately $50 million.
- Representation of Medical Nutrition USA, Inc. in its merger with and into Danone North America, Inc. for total merger consideration of approximately $60 million.
- Representation of Monterey Financial Services and Garrison Special Opportunities Fund LP in the purchase of all of the accounts receivable of Friedman’s Inc. for an aggregate purchase price of $63 million.
- Representation of Entravision Communications Corporation in the purchase and sale of several national radio and television stations.
- Representation of Volvo Construction Equipment North America, Inc. in its acquisition of all of the outstanding capital stock of Mathews Machinery, Inc.
- Representation of Averion International Corp. in its acquisition of all of the assets of Millennix Inc.
- Representation of Dunham Trust Company in its merger with Adagio Trust Company for approximately $5 million.
- Representation of Context Capital Management, LLC in its acquisition of all of the assets of TQA Investors, LLC. • Representation of Tell-A-Pal, Inc. in the sale of all of its assets to APAK Marketing, Inc.
Financings; Joint Ventures
- Representation of a public media company in its issuance of $300 million of Senior Notes in Rule 144A and Regulation S offering.
- Representation of Bermuda private company in the insurance industry in connection with the sale of its Series A Preferred Stock for approximately $100 million.
- Representation of Playas de Occidente, S.A. de C.V. in the issuance of $21 million in principal amount 10.5% senior secured bonds designated as eligible for trading through the Euroclear System and/or the Clearstream Settlement and Management System.
- Representation of EvoFem, Inc. in connection with the sale of its Series A Preferred Stock for approximately $25 million.
- Representation of Therasis Inc. in connection with the sale of its Series A Preferred Stock for approximately $12 million to Tilocor Life Science S.A.R.L.
- Representation of Brown Field International Business Park, LLC in the sale of equity interests to a syndicate of investors in the amount of $20M.
- Representation of Daylight Solutions, Inc. in connection with the sale of its Series A Preferred, Series B Preferred Stock and Series C Preferred Stock for an aggregate of approximately $35 million, including a strategic investment from Northrop Grumman Corporation in the amount of $15 million.
- Representation of Safe Life Corp. in connection with multiple bridge and preferred stock financings for an aggregate of approximately $22 million.
- Representation of Monterey Financial Services in connection with its credit facility with Sunrock Capital Corp. in the amount of $30 million.
- Representation of Truveris, Inc. in connection with its reorganization and sale of Series A Preferred Stock in the amount of $10M.
Alternative Energy; Project Finance; Real Estate
- Representation of PMCca, Inc. in connection with a hybrid construction and procurement contract for the development and construction of a geothermal power generation facility with a cost of approximately $500 million to be built by Hudson Ranch Power I, LLC, a subsidiary of EnergySource, LLC, near Niland, California entitled Hudson Ranch 1.
- Representation of PMCca, Inc. in connection with an engineering, procurement and construction contract for the development and construction of a geothermal power generation facility with a cost of approximately $500 million to be built by Hudson Ranch Power 2, LLC, a subsidiary of EnergySource, LLC, near Niland, California entitled Hudson Ranch 2.
- Representation of PMCca, Inc. in connection with an engineering, procurement and construction contract for the development and construction of at least two lithium extraction facilities with an aggregate cost of approximately $500 million to be built by Simbol Inc. near Niland, California, anticipated to be entitled “Sm Calipatria Plant 1” and “Sm Calipatria Plant 2.”